Life Sciences Archives - Page 4 of 7 - EverGlade Consulting

Life Sciences

Single-dose Vaccine

BARDA Issues RFI for Developing Single-Dose Pandemic Influenza Vaccine

Leave a Comment / All Posts, BARDA, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA), part of the Administration
for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human
Services (HHS), is seeking innovative ideas and strategies to develop a single-dose vaccine for pandemic
influenza. This Request for Information (RFI) is designed to gather valuable insights from
biopharmaceutical companies, research institutions, and vaccine development experts to facilitate the
creation of a vaccine that offers durable immunity with a single administration.

BARDA Issues RFI for Developing Single-Dose Pandemic Influenza Vaccine Read More »

Filovirus Monoclonal Antibodies

BARDA Announces RPP for Manufacturing Optimization for Filovirus Monoclonal Antibodies

Leave a Comment / All Posts, BARDA, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA) has issued a Request for Project Proposals (RPP) for “Manufacturing Optimization for Filovirus Monoclonal Antibodies.” The RPP was released on June 24, 2024, with proposals due by July 22, 2024. This initiative aims to enhance the manufacturing development of monoclonal antibody (mAb) cocktails targeting filoviruses like Ebola and Marburg viruses.

BARDA Announces RPP for Manufacturing Optimization for Filovirus Monoclonal Antibodies Read More »

African American woman in a technically advanced career

ARPA-H Announces Small Business Opportunities

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

The Advanced Research Projects Agency for Health (ARPA-H) has announced an upcoming solicitation for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) contracts for FY2024. The initiative targets innovative firms capable of conducting cutting-edge research and development, with a focus on commercializing the results. The solicitation includes opportunities for Phase I, Direct to Phase II, and Fast Track contracts.

ARPA-H Announces Small Business Opportunities Read More »

Abstract virus on blue background

BARDA Announces Request for Project Proposal to Establish Central Influenza and Emerging Infectious Diseases Vaccine Immunogenicity Laboratory Services

Leave a Comment / All Posts, BARDA, Life Sciences / By

Biomedical Advanced Research and Development Authority (BARDA) through the Rapid Response Partnership Vehicle (RRPV) initiative released a Request for Project Proposals (RPP) to establish Central Influenza and Emerging Infectious Diseases Vaccine Immunogenicity Laboratory Services to support vaccine development and response to pandemics and emerging infectious diseases.

BARDA Announces Request for Project Proposal to Establish Central Influenza and Emerging Infectious Diseases Vaccine Immunogenicity Laboratory Services Read More »

Medical Countermeasures through BARDA

BARDA Announces Request for Project Proposal for On-Demand Manufacturing

Leave a Comment / All Posts, BARDA, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA) is spearheading this effort with its innovative On-Demand Manufacturing program. This initiative is designed to revolutionize the production and distribution of MCMs by developing portable, continuous, and end-to-end manufacturing systems.

BARDA Announces Request for Project Proposal for On-Demand Manufacturing Read More »

BARDA Issues Amendment 4 to BAA for Medical Countermeasures R&D

BARDA Issues Amendment 4 to BAA for Medical Countermeasures R&D 

Leave a Comment / All Posts, BARDA, Life Sciences / By

BARDA has recently unveiled significant updates to its BAA, emphasizing a more refined and responsive approach to public health preparedness. Amendment 4 introduces crucial changes to the Areas of Interest designed to align BARDA’s efforts with the evolving landscape of global health threats.

BARDA Issues Amendment 4 to BAA for Medical Countermeasures R&D  Read More »

NIH Funding

New NIH Funding Opportunity – Investigating the Role of Genomic Variation on Gene Regulation and Disease

Leave a Comment / All Posts, Life Sciences, NIAID / By

At EverGlade Consulting, we are always on the lookout for new funding opportunities that can help our clients advance their research and development goals. Today, we’re excited to inform you about a new Request for Applications (RFA) from the National Institutes of Health (NIH): RFA-HG-24-004.

New NIH Funding Opportunity – Investigating the Role of Genomic Variation on Gene Regulation and Disease Read More »

BARDA Issues Amendment 3 to BAA for Medical Countermeasures R&D

BARDA Issues Amendment 3 to BAA for Medical Countermeasures R&D 

Leave a Comment / All Posts, BARDA, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA) has recently unveiled significant updates to its Broad Agency Announcement (BAA), emphasizing a more refined and responsive approach to public health preparedness. Amendment 3, in particular, brings crucial changes to the Areas of Interest (AOIs) that are designed to align BARDA’s efforts with the evolving landscape of global health threats. 

BARDA Issues Amendment 3 to BAA for Medical Countermeasures R&D  Read More »

Futuristic doctor with augmented reality tablet

A Comprehensive Guide to ARPA-H Funding: Process, Financial, and Technical Requirements

Leave a Comment / All Posts, ARPA-H, Guides, Life Sciences / By

The Advanced Research Projects Agency for Health (ARPA-H) stands as a beacon for those within the biomedical and health sectors, propelling transformative research initiatives and breakthroughs. The pursuit of funding from ARPA-H is a monumental stride for entities operating in these domains. This guide endeavors to navigate you through the intricate application process, the financial prerequisites, and the technical stipulations pivotal for securing ARPA-H funding

A Comprehensive Guide to ARPA-H Funding: Process, Financial, and Technical Requirements Read More »

Covid Research

EverGlade Consulting Lands ModeX Therapeutics Up to $168 Million in BARDA Funding

Leave a Comment / All Posts, BARDA, Life Sciences / By

EverGlade Consulting, a national consulting firm, has helped ModeX Therapeutics successfully secure up to $168 million in funding through a contract with the Biomedical Advanced Research and Development Authority (“BARDA”) to develop novel multispecific antibodies against viral infectious disease threats. How Funding Will Be Used The $168 million in BARDA funding will advance research and clinical trials for multispecific

EverGlade Consulting Lands ModeX Therapeutics Up to $168 Million in BARDA Funding Read More »

Wearable medical device

ARPA-H Solicits Proposals For REACT Program

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

Advanced Research Projects Agency (ARPA-H) Solicits Proposals for Resilient Extended Automatic Cell Therapies (REACT) Program The Advanced Research Projects Agency for Health (ARPA-H) is actively seeking innovative proposals through the Resilient Extended Automatic Cell Therapies (REACT) program, employing a Master Announcement Instruction (MAI) strategy for proposal submissions. This strategy enables proposers to tailor their submissions

ARPA-H Solicits Proposals For REACT Program Read More »

BARDA Post-Award represented with a digital drawing of virus and microscope

Effective Post-Award Management of a BARDA Contract

Leave a Comment / All Posts, BARDA, Guides, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA) plays a pivotal role in the United States’ preparedness for public health emergencies. BARDA contracts support the development, procurement, and deployment of medical countermeasures critical for safeguarding public health during crises. Once awarded a BARDA contract, effective post-award management becomes paramount to ensure the successful execution of

Effective Post-Award Management of a BARDA Contract Read More »

Scroll to Top

EverGlade Consulting

2025 Proposal Package

Submit 1 proposal, SAVE UP TO 20% Submit 2 proposals, SAVE UP TO 60% Submit 3 proposals, SAVE UP TO 73% Submit 4 proposals, SAVE UP TO 80%
Inquire Now